Hemab Therapeutics Holdings (COAG) PT Raised to $47 at Jefferies
Tweet
Share
E-mailGet Alerts COAG Hot Sheet
Price: $44.41 +0.09%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Jefferies analyst Maury Raycroft raised the price target on Hemab Therapeutics Holdings (NASDAQ: COAG) to $47.00 (from $39.00) while maintaining a Buy rating.
You May Also Be Interested In
- Hindustan Unilever Ltd (HUVR:IN) PT Lowered to INR2,440 at HSBC
- Shoprite Holdings Ltd. (SHP:SJ) (SRHGF) PT Raised to ZAR368 at JPMorgan
- Lululemon (LULU) PT Lowered to $115 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
